HYFT
ImmunoPrecise Antibodies Ltd.NASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage limited
Factor tilt: Anti-Momentum Micro Cap
$1.48+5.71%
Close Oct 13, 2026
- Market cap
- $69.27M
- 1 month
- +11.3%
- 3 months
- -0.7%
- 1 year
- -18.2%
- 52-week range
- $1.02$2.78
- Dividend
- No dividends on record
- Short interest
- 707.3K sharessettled Sep 30, 2026 · -3.1% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if HYFT is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: UNKNOWN
1 top institutions tracked
as of 2025-Q4 (filed 2026-02-14)
Note: 13F filings are reported up to 45 days after quarter-end.Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
27 filers reported a long position in HYFT for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| INGALLS & SNYDER LLC | $4.8M | 3M | +4.4% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $822.8K | 520.8K | -2.5% |
| RENAISSANCE TECHNOLOGIES LLC | $337.1K | 213.4K | -8.2% |
| BlackRock, Inc. | $244K | 154.4K | New |
| MARSHALL WACE, LLP | $214.8K | 136K | +438.6% |
| BANK OF MONTREAL /CAN/ | $123.2K | 77.9K | +11.4% |
| Allianz Asset Management GmbH | $55.3K | 35K | Unchanged |
| GSA CAPITAL PARTNERS LLP | $55K | 34.5K | New |
| Gradient Capital Advisors, LLC | $42K | 26.6K | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $40.3K | 25.5K | +58% |
Get the Full Analysis for HYFT
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.